2fd6: Difference between revisions

New page: left|200px<br /> <applet load="2fd6" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fd6, resolution 1.90Å" /> '''Structure of Human ...
 
No edit summary
Line 1: Line 1:
[[Image:2fd6.gif|left|200px]]<br />
[[Image:2fd6.gif|left|200px]]<br /><applet load="2fd6" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2fd6" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2fd6, resolution 1.90&Aring;" />
caption="2fd6, resolution 1.90&Aring;" />
'''Structure of Human Urokinase Plasminogen Activator in Complex with Urokinase Receptor and an anti-upar antibody at 1.9 A'''<br />
'''Structure of Human Urokinase Plasminogen Activator in Complex with Urokinase Receptor and an anti-upar antibody at 1.9 A'''<br />


==Overview==
==Overview==
The urokinase plasminogen activator binds to its cellular receptor with, high affinity and initiates signaling cascades that are implicated in, pathological processes including tumor growth, metastasis, and, inflammation. We report the crystal structure at 1.9 angstroms of the, urokinase receptor complexed with the urokinase amino-terminal fragment, and an antibody against the receptor. The three domains of urokinase, receptor form a concave shape with a central cone-shaped cavity where the, urokinase fragment inserts. The structure provides insight into the, flexibility of the urokinase receptor that enables its interaction with a, wide variety of ligands and a basis for the design of urokinase-urokinase, receptor antagonists.
The urokinase plasminogen activator binds to its cellular receptor with high affinity and initiates signaling cascades that are implicated in pathological processes including tumor growth, metastasis, and inflammation. We report the crystal structure at 1.9 angstroms of the urokinase receptor complexed with the urokinase amino-terminal fragment and an antibody against the receptor. The three domains of urokinase receptor form a concave shape with a central cone-shaped cavity where the urokinase fragment inserts. The structure provides insight into the flexibility of the urokinase receptor that enables its interaction with a wide variety of ligands and a basis for the design of urokinase-urokinase receptor antagonists.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
2FD6 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with NAG, SO4, ETX, PG4, EDO and PGE as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/U-plasminogen_activator U-plasminogen activator], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.73 3.4.21.73] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2FD6 OCA].  
2FD6 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=SO4:'>SO4</scene>, <scene name='pdbligand=ETX:'>ETX</scene>, <scene name='pdbligand=PG4:'>PG4</scene>, <scene name='pdbligand=EDO:'>EDO</scene> and <scene name='pdbligand=PGE:'>PGE</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/U-plasminogen_activator U-plasminogen activator], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.73 3.4.21.73] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FD6 OCA].  


==Reference==
==Reference==
Line 35: Line 34:
[[Category: upar]]
[[Category: upar]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:03:34 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:20:13 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA